⌘K

Login Start Free

Home/Filings/4/0000875320-25-000141

4//SEC Filing

Tatsis Ourania 4

Accession 0000875320-25-000141

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:08 PM ET

Size

4.7 KB

Accession

0000875320-25-000141

Insider Transaction Report

Form 4

Period: 2025-03-04

VERTEX PHARMACEUTICALS INC / MAVRTX

EVP, Chief Reg. & Quality Off.

Transactions

Sale
Common Stock
2025-03-04$485.49/sh−4,058$1,970,118→ 54,481 total

Footnotes (1)

[F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024.

Documents

1 file

4
wk-form4_1741295323.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001789815

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:08 PM ET
Size: 4.7 KB

View on SEC.gov